Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01093378
Other study ID # P071224
Secondary ID
Status Completed
Phase N/A
First received February 26, 2010
Last updated August 28, 2015
Start date October 2009
Est. completion date June 2015

Study information

Verified date August 2015
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority France: Ministry of Health
Study type Observational

Clinical Trial Summary

This case-control multicentric study involving fertile and infertile couples aims at evaluating the impact on conception rate of nutritional parameters (biologic, clinic, anthropometric, and food questionnaire).


Description:

Infertility affects about 15% of couples. Many factors relating to lifestyle and environment are likely to influence fertility. As an adapted nutrition could prevent 30% of cancers, diet could be essential, but largely neglected, in the prevention of infertility.

Some studies tried to explore the impact of diet on male or female fertility, but very few focused on both. The aim of our study is to assess the role of nutrition in both fertile and infertile couples, taking into account most of factors relating to lifestyle. Clinical, anthropometric (BMI, fat mass), biological markers (non specific - glycaemia, lipids, inflammation, electrolytes - and specific - vitamins E, A, C, D, B, including folates and MTHFR polymorphism) and semen analysis, will be combined with validated questionnaires (nutrition, drugs, alcohol, tobacco, physical activity, sleep and stress).

The statistical analysis of correlations between nutritional and clinical data will provide information concerning the impact of nutrition on fertility.


Recruitment information / eligibility

Status Completed
Enrollment 400
Est. completion date June 2015
Est. primary completion date October 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

Common to both infertile and fertile couples:

- Couples where both members are over eighteen and at childbearing age (=38 for women and = 45 for men)

- Couples where both members agreed to take part in the study

- Couples where both members completed a medical check-up and gave an informed consent. Infertile couples could be included following a medical consultation for infertility

- Couples with none of its member facing any comprehension difficulty in oral or written French language

- Couples where both members are affiliated to the French NHS [national health service] (beneficiary or legal claimant)

Specific to fertile couples:

- fertile couples who naturally and spontaneously conceived a or many children with a time to conceive shorter than 12 months.

Specific to infertile couples:

- Infertile couples (primary, infertility, inability to conceive a child after 12 months of unprotected sexual intercourse)

- Couples where the male partner has sperm parameters compatible with a natural conception

- Couples where the female partner does not present anovulation, ovarian insufficiency and or any uterus-tubal pathology

Exclusion Criteria:

Common to both infertile and fertile couples:

- couples where one of the members is under eighteen or not a childbearing age (>38 for women an >45 for men)

- couples where at least one member refused to give written agreement for the study

- couples where at least one member shows any known cardiovascular risk (diabetes, hypercholesterolemia, HBR)

- couples where at least one member shows any known cardiovascular pathology, digestive pathology, no good absorptive pathology or a cancer

- couples where at least one member faces some difficulty in understanding French language

- couples where at least one member is not affiliated with the French NHS (beneficiary or legal claimant)

Specific to fertile couples:

•Couples where the woman had a miscarriage or medical termination of pregnancy with current partner

Specific to infertile couples:

- Couples in which it is not the first pregnancy

- Couples with the male member showing either:

- severe oligozoospermia (<5 millions/ml) or a confirmed azoospermia (absence of spermatozoid in the ejaculate)

- a moderate non idiopathic oligozoospermia (5-20 millions/ml), related to one more of the following factors:

1. toxic (chemotherapy, radiotherapy, drugs with a demonstrated effect on spermatogenesis)

2. infectious

3. anatomic: vasectomy, congenital anomaly (agenesis of vas deferens), long post-traumatic ischemia

4. endocrine: hypogonadotropic, hypogonadism

5. cytogenetic: klinefelter syndrome, translocation

- couples whose male partner shows an abnormality of the male genital tractus : VARICOCEME undescended,testis, testicular volume < 12ml

- couples whose female partner presents an anovulation, ovarian insufficiency or a proven uterus-tubal pathology

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Locations

Country Name City State
France Laboratoire d'Histologie- Embryologie - Cytogénétique - CECOS Bondy

Sponsors (3)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris Institut National de la Santé Et de la Recherche Médicale, France, University Paris 7 - Denis Diderot

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluate the nutritional status of fertile and infertile couples (food questionnaire - biologic, anthropometric and clinical balance). 24 hours No
Secondary Impact of genetic polymorphism on clinical and biological phenotypes linked to food behaviour in infertility context (MTHFR polymorphism for folates metabolism) 12 months No
Secondary Impact of lifestyle (alcohol and tabacco consumption, physical activity, anxiety and sleep) on diet and fertility 24 hours No
Secondary Impact of nutritional status on fertility and ART parameters 24 hours No
Secondary Fertility : time to pregnancy (TTP) in the 6 months No
Secondary Male infertility : quantitative or qualitative semen abnormalities in the 6 months No
Secondary Pregnancy and obstetrical pathologies, prematurity, twin birth, weight of the new-born in infertile couples in the 6 months No
Secondary ART parameters, if appropriate in the 6 months No
See also
  Status Clinical Trial Phase
Completed NCT03607409 - Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
Recruiting NCT02312076 - GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles Phase 4
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Completed NCT03287479 - Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®) N/A
Terminated NCT03522350 - Randomized Trial Comparing EmbryoScope With EmbryoScope+. N/A
Completed NCT04496284 - Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen N/A
Completed NCT03623659 - pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts N/A
Completed NCT03895099 - New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors Phase 3
Active, not recruiting NCT04142112 - Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation N/A
Completed NCT03152643 - Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer N/A
Recruiting NCT03683771 - Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
Recruiting NCT03161119 - Comparing Two Different Embryo Transfer Catheters N/A
Completed NCT04108039 - Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. N/A
Completed NCT03678610 - Handling Medium for ICSI With Ionomycin and Latrunculin A N/A
Completed NCT03678818 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA) N/A
Completed NCT03678571 - Oocyte Vitrification Aided With Latrunculin A N/A
Completed NCT03678597 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB) N/A
Completed NCT03678584 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA) N/A
Completed NCT03677492 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD) N/A
Completed NCT03678558 - Oocyte Vitrification Aided With Cytochalasin B N/A